MZE829 clinical trials

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

This study is testing a new medicine, MZE829, for adults with a specific type of kidney disease called APOL1-mediated kidney disease. We want to see how safe it is, how well people tolerate it, and if it can reduce protein in the urine, which is a sign of kidney damage.